Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Rolf Jautelat
Observed names:
Jautelat, R.,
R. JAUTELAT,
R. Jautelat
Institution:
Bayer (Germany)
Observed institutions:
Leibniz University Hannover,
Scripps Research Institute,
University of California San Diego,
Bayer (Germany)
OpenAlex ID:
A5031243988
Discovery of the Soluble Guanylate Cyclase Stimulator Vericiguat (BAY 1021189) for the Treatment of Chronic Heart Failure
2017
·
Markus Follmann
, Jens Ackerstaff
, et al.
·
Journal of Medicinal Chemistry
·
216
The Lab Oddity Prevails: Discovery of Pan‐CDK Inhibitor (R)‐S‐Cyclopropyl‐S‐(4‐{[4‐{[(1R,2R)‐2‐hydroxy‐1‐methylpropyl]oxy}‐5‐(trifluoromethyl)pyrimidin‐2‐yl]amino}phenyl)sulfoximide (BAY 1000394) for the Treatment of Cancer
2013
·
Ulrich Lücking
, Rolf Jautelat
, et al.
·
ChemMedChem
·
186
Progress in the Chemistry of Organic Natural Products
2004
·
H. Budzikiewicz
, T. Flessner
, et al.
·
Springer eBooks
·
90
From the Insoluble Dye Indirubin towards Highly Active, Soluble CDK2‐Inhibitors
2005
·
Rolf Jautelat
, Thomas Brumby
, et al.
·
ChemBioChem
·
82
Preclinical Efficacy of the Auristatin-Based Antibody–Drug Conjugate BAY 1187982 for the Treatment of FGFR2-Positive Solid Tumors
2016
·
Anette Sommer
, Charlotte Kopitz
, et al.
·
Cancer Research
·
76
Discovery of Rogaratinib (BAY 1163877): a pan‐FGFR Inhibitor
2018
·
Marie‐Pierre Collin
, Mario Lobell
, et al.
·
ChemMedChem
·
63
Treating Cancer by Spindle Assembly Checkpoint Abrogation: Discovery of Two Clinical Candidates, BAY 1161909 and BAY 1217389, Targeting MPS1 Kinase
2020
·
Volker K. Schulze
, Ulrich Klar
, et al.
·
Journal of Medicinal Chemistry
·
60
Directed Synthesis of Nonsymmetrical Bis‐Steroidal Pyrazines and the First Biologically Active Cephalostatin Analogues
1996
·
Michael Drögemüller
, Rolf Jautelat
, et al.
·
Angewandte Chemie International Edition in English
·
54
Macrocyclic Aminopyrimidines as Multitarget CDK and VEGF‐R Inhibitors with Potent Antiproliferative Activities
2006
·
Ulrich Lücking
, Gerhard Siemeister
, et al.
·
ChemMedChem
·
50
Preclinical Antitumor Efficacy of BAY 1129980—a Novel Auristatin-Based Anti-C4.4A (LYPD3) Antibody–Drug Conjugate for the Treatment of Non–Small Cell Lung Cancer
2017
·
Jörg Willuda
, Lars Linden
, et al.
·
Molecular Cancer Therapeutics
·
45
Studies towards Trichodimerol: Novel Cascade Reactions and Polycyclic Frameworks
1999
·
K. C. Nicolaou
, Rolf Jautelat
, et al.
·
Chemistry - A European Journal
·
43
PDF
Synthesis of Cephalostatin Analogues by Symmetrical and Non-Symmetrical Routes
1998
·
Michael Drögemüller
, Timo Flessner
, et al.
·
European Journal of Organic Chemistry
·
42
PDF
Synthesis of Cytostatic Tetradecacyclic Pyrazines and a Novel Reduction-Oxidation Sequence for Spiroketal Opening in Sapogenins
2000
·
Siegfried Bäsler
, Annette Brunck
, et al.
·
Helvetica Chimica Acta
·
38
A Novel Route to the Fused Maleic Anhydride Moiety of CP Molecules
1999
·
K. C. Nicolaou
, Phil S. Baran
, et al.
·
Angewandte Chemie International Edition
·
29
New Generation of sGC Stimulators: Discovery of Imidazo[1,2-a]pyridine Carboxamide BAY 1165747 (BAY-747), a Long-Acting Soluble Guanylate Cyclase Stimulator for the Treatment of Resistant Hypertension
2023
·
Alexandros Vakalopoulos
, Frank Wunder
, et al.
·
Journal of Medicinal Chemistry
·
19
Cephalostatin Analogues — Synthesis and Biological Activity
2004
·
Timo Flessner
, Rolf Jautelat
, et al.
·
Springer eBooks
·
19
A Novel Oxidative Cleavage of the Steroidal Skeleton
1999
·
Rolf Jautelat
, Anke Müller-Fahrnow
, et al.
·
Chemistry - A European Journal
·
17
PDF
Ein außergewöhnlicher Zugang zur anellierten Maleinsäureanhydrid-Einheit der CP-Moleküle
1999
·
K. C. Nicolaou
, Phil S. Baran
, et al.
·
Angewandte Chemie
·
13
Gelenkte Synthese unsymmetrischer bis‐steroidaler Pyrazine und die ersten biologisch aktiven Cephalostatin‐Analoga
1996
·
Michael Drögemüller
, Rolf Jautelat
, et al.
·
Angewandte Chemie
·
13
Photochemistry of Hecogenine Acetate Revisited
1996
·
R. Jautelat
, E. Winterfeldt
, et al.
·
Journal für praktische Chemie
·
13
Abstract 1739: Preclinical profile of BAY 1163877 - a selective pan-FGFR inhibitor in phase 1 clinical trial
2014
·
Melanie Heroult
, Peter Ellinghaus
, et al.
·
Cancer Research
·
10
Cover Picture: The Lab Oddity Prevails: Discovery of Pan‐CDK Inhibitor (R)‐S‐Cyclopropyl‐S‐(4‐{[4‐{[(1R,2R)‐2‐hydroxy‐1‐methylpropyl]oxy}‐5‐(trifluoromethyl)pyrimidin‐2‐yl]amino}phenyl)sulfoximide (BAY 1000394) for the Treatment of Cancer (ChemMedChem 7/2013)
2013
·
Ulrich Lücking
, Rolf Jautelat
, et al.
·
ChemMedChem
·
8
PDF
416 Simultaneous targeting of tumor cell proliferation and tumor-induced neoangiogenesis by the novel CDK2/VEGF-RTK dual pathway inhibitor ZK-CDK
2004
·
G. Siemeister
, H. Briem
, et al.
·
European Journal of Cancer Supplements
·
2
Abstract 46: Preclinical activity of novel antibody-drug conjugates with pyrrole-based kinesin spindle protein inhibitors targeting different tumor antigens
2017
·
Anette Sommer
, Sandra Berndt
, et al.
·
Cancer Research
·
1
Abstract 4491: FGFR2-ADC potently and selectively inhibits growth of gastric and breast cancer xenograft models
2014
·
Anette Sommer
, Carl F. Nising
, et al.
·
Cancer Research
·
1
Show more works
View as search
Works count:
82
Citation count:
1,192
H-index:
17
I10-index:
21
Year
Topic
Type
